Evidence map›Paper›PMID 40397251›Full record

ArticleMolecular biology reports2025

Antibacterial and antibiofilm efficacy of eugenol, carvacrol, and cinnamaldehyde against colistin-resistant Klebsiella pneumoniae.

Milad Kashi, Abbas Farahani, Azam Ahmadi, Aref Shariati, Majid Akbari

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Carvacrol exhibits potent anti-Frontiers in pharmacology · 2026
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Milad KashiStudent Research Committee, Arak University of Medical Sciences, Arak, Iran.
Abbas FarahaniMolecular Medicine Research Center, Khomein University of Medical Sciences, Khomein, Iran.
Azam AhmadiInfectious Diseases Research Center (IDRC), Arak University of Medical Sciences, Arak, Iran.
Aref ShariatiInfectious Diseases Research Center (IDRC), Arak University of Medical Sciences, Arak, Iran. arefshariati0111@gmail.com.
Majid AkbariInfectious Diseases Research Center (IDRC), Arak University of Medical Sciences, Arak, Iran.

Funding

Arak University of Medical Sciences 7341
6 · The paper itself

Abstract

backgroundColistin-resistant Klebsiella pneumoniae (CR K. pneumoniae) is considered one of the bacteria with the highest levels of antibiotic resistance, necessitating the discovery of alternative therapeutic strategies. This study aimed to evaluate the ability of eugenol, carvacrol, and cinnamaldehyde to inhibit CR K. pneumoniae and the biofilm community of this bacterium.

methodThe minimum inhibitory concentration (MIC) and antibiofilm effects of compounds were assessed using broth macrodilution and microtiter plate assays, respectively. Time-kill assays determined the bactericidal effects of natural compounds on CR K. pneumoniae isolates. Protein and nucleic acid leakage were examined to assess metabolic disruption and cell membrane integrity. Real-time PCR was used to evaluate the effect of natural compounds on the expression of biofilm-related genes (mrkA, treC, and luxS).

resultsIn the disk diffusion test, the inhibition zones of eugenol, carvacrol, and cinnamaldehyde were 15 ± 1, 29 ± 2, and 30 ± 1 mm, respectively. The MIC of eugenol, carvacrol, and cinnamaldehyde were 260, 119, and 128 µg/mL, respectively. The time-kill assay demonstrated the rapid bactericidal effects of eugenol, carvacrol, and cinnamaldehyde at 2× MIC, with kill times of 6, 2, and 3 h, respectively. At the MIC, the kill times were 12, 10, and 12 h, respectively. These compounds significantly released proteins and nucleic acids from the treated bacteria. They also inhibited biofilm formation and disrupted mature biofilms. Furthermore, mrkA and treC expression levels were significantly reduced in the presence of eugenol and cinnamaldehyde.

conclusionThese natural compounds demonstrated significant antibacterial and antibiofilm activity against CR K. pneumoniae, emerging as a promising natural alternative for treatment.

Indexed as

AcroleinBiofilmsEugenolKlebsiella pneumoniaeAnti-Bacterial AgentsColistinCymenesDrug Resistance, BacterialMicrobial Sensitivity TestsMonoterpenesAcroleinAnti-Bacterial AgentscarvacrolcinnamaldehydeColistinCymenesEugenolMonoterpenesBiofilmCarvacrolCinnamaldehydeColistin-resistantEugenolKlebsiella pneumoniae

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.